-The Wall Street Journal   While modern crop engineering faces endless red tape, more slipshod cross-breeding gets a free pass. India has enjoyed signal successes with genetic engineering in agriculture. But today the nation's relationship with this critical biotechnology is in total disarray, the victim of activists' scaremongering and government pandering. Delhi should know better. Following the adoption of the genetically improved varieties and intensive crop management practices of the Green Revolution, from 1960...

-The Indian Express Cash transfers seem to be the latest fad. With elections looming, the Prime Minister’s National Committee on Direct Cash Transfers has been tasked with an ambitious mandate to provide vision and direction to enable direct cash transfers of subsidies under various government schemes and programmes to individuals to enhance efficiency. Certain activists warn against an ill-considered and hasty transition from food to cash. Others believe directly transferring the...

-The Indian Express Nearly 45 trillion bidis and cigarettes manufactured over the past 100 years in the country are expected to be responsible for nearly 100 million deaths of adult Indians, a recent study has found. "Our calculations are derived from using the most conservative estimates and yet present mortality estimates which are significant and alarming," researchers Pranay G Lal, Nevin C Wilson and Prakash C Gupta said in a study published...

-The Times of India The Prime Minister is expected to formally kick off cash transfer of subsidies and entitlements, one of the most ambitious policy initiatives of UPA-2, on Monday. The scheme for cash transfers is visualized as a game-changer for UPA-2, like NREGA was for UPA-1, and is expected to give rich dividends at the elections. Manmohan Singh is expected to set January 1, 2013 as the launch date for the...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...